ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.63
      0.02%
      US Tech 100
      17,060.40
      0.00%
      Dow Jones
      38,460.92
      -0.11%
      Brent Oil
      87.47
      0.29%
      Bitcoin
      64,030.14
      -0.39%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Redhill Biopharma Ltd (RDHL)

      7. Redhill Biopharma Ltd (RDHL) News

      RDHL Redhill Biopharma Ltd

      0.4199
      0.00 (0.00%)
      Apr 24 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Redhill Biopharma Ltd RDHL NASDAQ Depository Receipt
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 0.4199 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      0.4199
      more quote information »

      Recent News

      Date Time Source Heading
      4/24/202407:00PRNUSRedHill Announces First Patient Enrolled in U.S...
      4/08/202409:23PRNUSRedHill Biopharma Announces Full-Year 2023 Results and..
      4/02/202407:00PRNUSRedHill Biopharma Announces $1.25 Million Registered Direct..
      3/11/202407:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      3/11/202407:00PRNUSRedHill Announces New USPTO Patent Covering Talicia® Through..
      3/05/202407:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      3/05/202407:00PRNUSRedHill's Opaganib Selected for Evaluation by BARDA and NIH..
      2/20/202416:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/20/202407:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/20/202407:00PRNUSRedHill's Opaganib Protects Against Radiation-Induced Lung..
      2/16/202408:54EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      2/16/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
      2/13/202416:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/02/202416:10EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      2/01/202410:22EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      1/26/202412:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/26/202412:46PRNUSRedHill Biopharma Announces Closing of $8 Million Registered..
      1/26/202409:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/26/202409:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      1/25/202409:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/25/202409:05PRNUSRedHill Biopharma Announces $8 Million Registered Direct..
      1/25/202406:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/25/202406:00PRNUSRedHill Announces New USPTO Patent Grant for Talicia® for H...
      12/20/202308:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/20/202308:45PRNUSRedHill and U.S. Army Announce Opaganib and RHB-107..
      12/12/202307:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/12/202307:00PRNUSRedHill Biopharma Regains Compliance with Nasdaq Minimum Bid..
      12/06/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/04/202307:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/04/202307:00PRNUSRedHill Announces New, Non-Dilutive External Funding of..
      12/01/202316:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/27/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/27/202307:00PRNUSRedHill Biopharma Announces FDA Grant of 5-Year U.S. Market..
      11/16/202312:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/14/202308:00PRNUSRedHill Biopharma Announces the Transfer of its Listing to..
      10/26/202316:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      10/23/202316:06EDGAR2Form F-3/A - Registration statement by foreign private..
      10/16/202316:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/13/202308:13EDGAR2Form F-3 - Registration statement by foreign private issuers
      10/10/202309:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/03/202307:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/03/202307:00PRNUSRedHill and U.S. Army Announce Opaganib's Ebola Virus..
      9/29/202308:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/22/202316:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/22/202316:15PRNUSRedHill Biopharma Announces Receipt of Nasdaq Notification..
      9/18/202307:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/18/202307:00PRNUSRedHill Announces FDA sNDA Approval for Talicia®
      9/05/202307:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/05/202307:00PRNUSRedHill Announces New USPTO Notice of Patent Allowance for..
      8/17/202307:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

      Your Recent History

      NASDAQ
      RDHL
      Redhill Biopharma
      Delayed Upgrade Clock